Roy, Simanta
Chowdhury, Sreshtha
Ferdous, Tarana
Shihadeh, Alan
Salman, Rola
El Hage, Rachel
Salam, Sally
Bursac, Zoran
Maziak, Wasim
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA053587 and R01DA055937)
Article History
Received: 8 April 2026
Accepted: 5 June 2026
First Online: 13 June 2026
Declarations
Competing interests: The authors declare no competing interests.
Human ethics and consent to participate: The study obtained approval from the Institutional Review Board of Florida International University (FIU). The original studies were registered with ClinicalTrials.gov (NCT05338801, registration date: 2022-04-04; NCT05205382, registration date: 2021-12-15). All participants provided written informed consent before participating in the study.
Declaration of AI use: During the preparation of this work, the authors used AI tools (Grammarly, ChatGPT, Claude) to improve clarity, grammar, and readability of the text. After using this tool, the authors reviewed and edited the content, taking full responsibility for the manuscript’s content.